<DOC>
	<DOCNO>NCT02753504</DOCNO>
	<brief_summary>The purpose study investigate safety/tolerability pharmacokinetics/pharmacodynamics CKD-519</brief_summary>
	<brief_title>Study Investigate Safety/Tolerability Pharmacokinetics/Pharmacodynamics CKD-519</brief_title>
	<detailed_description>A Dose-block Randomized , Double-blind , Placebo-controlled , Multiple Dosing , Dose-escalation Phase I Clinical Trial Investigate Safety/Tolerability Pharmacokinetics/Pharmacodynamics CKD-519 After Oral Administration Healthy Adult Volunteers</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>1 . Between 19 age 55 age healthy adult 2 . Body weight 55kg male , 50kg female 3 . Body Mass Index 18.5 25 ( body mass index=kg/m2 ) 4 . If female , must include one among item The menopause ( natural menses least 2 year ) Surgical Infertility ( hysterectomy bilateral oophorectomy , tubal ligation method infertility condition 5 . If men sexual life woman childbearing age , Necessarily agree use condom sperm donation two month clinical trial final dosage investigational product 6 . Those fully understand clinical trial enough hearing , decide join clinical trial comply precaution write consent 1 . Have clinically significant disease hepatobiliary system ( severe hepatic impairment , etc ) , kidney ( severe renal impairment , etc ) , nervous system , immune system , respiratory system , endocrine system , hematooncology disease , cardiovascular system ( heart failure , etc ) mental illness , history mental disease . 2 . Have history Toresades de pointes ( TdP ) additional risk factor Toresades de pointes ( TdP ) . ( Family history long QT syndrome sudden death , heart failure , hypokalemia , etc ) 3 . Have gastrointestinal disease history effect drug absorption ( Crohn 's disease , ulcer , etc . ) surgery ( except simple appendectomy hernia surgery ) 4 . Hypersensitivity reaction clinically significant hypersensitivity reaction history drug additives . 5 . An impossible one participate clinical trial include screen test ( medical history taking , BP , 12lead ECG , physical examination , blood &amp; urine laboratory test result ) 28 day take investigational Products . 6 . Defined follow laboratory parameter AST , ALT &gt; 1.25 upper limit normal range Total bilirubin &gt; 1.5 upper limit normal range CPK &gt; 1.5 upper limit normal range eGFR ( use MDRD method ) &lt; 60mL/min/1.73m2 7 . Defined follow 12lead ECG HR &lt; 40 &gt; 110bpm PR interval &gt; 220ms â‰¤110ms QRS interval &gt; 120ms QTcF &lt; 300ms &gt; 450ms Pathologic Qwaves ( define &gt; 40ms depth &gt; 0.5mV ) Incomplete complete bundle branch block Preexcitation ( e.g. , WolfeParkinsonWhite Syndrome ) Atrial fibrillation/flutter Second thirddegree atrioventricular ( AV ) block Investigator judge unfavorable consistently accurate QT measurement ( e.g. , indistinct QRS onset , low amplitude T wave , invert terminally inverted T wave , merge T/U wave , indistinct T wave offset , prominent U wave affect QT measurement ) 8 . Sitting SBP &gt; 150mmHg &lt; 90mmHg , sit DBP &gt; 100mmHg &lt; 50mmHg , 5 minute break . 9 . Drug abuse history drug abuse showes positive urine drug test . 10 . Pregnant lactating woman . 11 . A heavy caffeine consumer ( caffeine &gt; 5 cups/day ) , alcohol consumer ( alcohol &gt; 210g/week ) , smoker ( cigarette &gt; 10 cigarettes/day ) 12 . Subject take ethical drug herbal medicine within 14 day , OTC within 7 day begin study treatment investigator determine take drug affect study could affect safety subject . 13 . Subject take inhibitor inducer drug metabolize enzyme ( Barbiturates etc . ) within 30 day . 14 . Taking concomitant medication prolong QT/QTc interval within 14 day begin study treatment . 15 . Taking food contain grapefruit within 7 day begin study treatment ( ex . Drinking contain grapefruit 1L per day within 7 day begin study treatment ) 16 . Subject treat investigational drug within 90 day begin study treatment 17 . Previously donate whole blood within 60 day component blood within 30 day . 18 . An impossible one participant clinical trial investigator 's decision include laboratory test result another reason . 19 . Positive Serology test ( Hepatitis B , Hepatitis C , HIV )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Dyslipidemia</keyword>
</DOC>